33 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
approval efforts and significantly increase VBL’s costs to recover or reproduce the data. To the extent that any disruption or security incident results … data may have been affected by the breach. In addition, VBL’s efforts to contain or remediate a security incident or any vulnerability exploited
S-4/A
d92p9d1etinuub8
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
EX-10.20
ulw1a
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
515u01adovb4d4
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.11
1sl dkvr4n3
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-1.1
bhgb0aqueerhod6xi
11 Feb 22
Current report (foreign)
5:29pm
POS AM
cs2pql7tp
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
6-K
EX-1.1
09hh9jup8ferhe
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.1
c5w tl38gui3r4cldh
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
67bcc7ciwm41ynsj
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-1
ie4e4uu8t46tkp9242
1 Jun 20
Registration statement (foreign)
12:18pm
6-K
EX-10.1
tiqy yk7uet
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
vm1ygk42nt01eq4inu
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am